Anthem, Cigna merger squabbles could delay antitrust approval: WSJ
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Anthem (ANTM): Time To Consider It As A Standalone Company - FBR (CI)
May 23, 2016 8:57 AM EDTFBR Capital analyst, Steven Halper, views the Anthem (NYSE: ANTM)/Cigna (NYSE: CI) merger as less likely to close and thinks investors need to view the companies on their individual merits.
Over the weekend, the Wall Street Journal reported that discord exists between Anthem and... More
